These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5883214)

  • 1. Analogs of tetrahydrofolic acid. XXVII. Hydrophobic bonding to dihydrofolic reductase by 2-amino-4,6-disubstituted-5-alkylpyrimidines and 1-alkyl-4,6-diamino-1,2-dihydro-s-triazines.
    Baker BR; Beng-Thong Ho; Santi DV
    J Pharm Sci; 1965 Oct; 54(10):1415-24. PubMed ID: 5883214
    [No Abstract]   [Full Text] [Related]  

  • 2. Irreversible enzyme inhibitors. LXXXVI. Hydrophobic bonding to dihydrofolic reductase. 8. Substituted-1-aryl-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazines.
    Baker BR; Ho BT; Lourens GJ
    J Pharm Sci; 1967 Jun; 56(6):737-42. PubMed ID: 5231391
    [No Abstract]   [Full Text] [Related]  

  • 3. Analogs of tetrahydrofolic acid XXV. 2,4-Diamino-6-phenethylpteridine, an inhibitor of dihydrofolic reductase.
    Baker BR; Ho BT
    J Pharm Sci; 1965 Sep; 54(9):1261-5. PubMed ID: 5881216
    [No Abstract]   [Full Text] [Related]  

  • 4. Analogs of tetrahydrofolic acid. 33. Hydrophobic bonding to dihydrofolic reductase V. Inhibition by some pyrimidines bridged to benzoic acid.
    Baker BR; Ho BT; Coward JK; Santi DV
    J Pharm Sci; 1966 Mar; 55(3):302-8. PubMed ID: 5960176
    [No Abstract]   [Full Text] [Related]  

  • 5. Analogs of tetrahydrofolic acid 34. Hydrophobic bonding to dihydrofolic reductase VI. Mode of phenyl binding of some 6-arylpyrimidines.
    Baker BR; Shapiro HS
    J Pharm Sci; 1966 Mar; 55(3):308-17. PubMed ID: 5960177
    [No Abstract]   [Full Text] [Related]  

  • 6. Analogs of tetrahydrofolic acid XXIV. Further observations on the mode of pyrimidyl binding to dihydrofolic reductase and thymidylate synthetase by the 2-amino-5-(3-anilinopropyl)-6-methyl-4-pyrimidinol type of inhibitor.
    Baker BR; Santi DV
    J Pharm Sci; 1965 Sep; 54(9):1252-7. PubMed ID: 5881214
    [No Abstract]   [Full Text] [Related]  

  • 7. Analogs of tetrahydrofolic acid XX. Effects of modification of the bridge between the pyrimidyl and phenyl moieties of 2-amino-5-(3-anilinopropyl)-6-methyl-4-pyrimidinol on inhibition of dihydrofolic reductase and thymidylate synthetase II.
    Baker BR; Ho BT
    J Pharm Sci; 1965 Aug; 54(8):1187-90. PubMed ID: 5882225
    [No Abstract]   [Full Text] [Related]  

  • 8. Irreversible enzyme inhibitors. LXXXVII. Hydrophobic bonding to dihydrofolic reductase. IX. Mode of binding of m-aryloxyalkyl groups on 4,6-diamino-1,2-dihdro-2,2-dimethyl-1-phenyl-s-triazine.
    Baker BR; Lourens GJ
    J Pharm Sci; 1967 Jul; 56(7):871-5. PubMed ID: 6068108
    [No Abstract]   [Full Text] [Related]  

  • 9. Analogs of tetrahydrofolic acid. 32. Hydrophobic bonding to dihydrofolic reductase IV. Inhibition by p-substituted benzoic and benzoyl-L-glutamic acids.
    Baker BR; Schwan TJ; Novotny J; Ho BT
    J Pharm Sci; 1966 Mar; 55(3):295-302. PubMed ID: 5960175
    [No Abstract]   [Full Text] [Related]  

  • 10. Irreversible enzyme inhibitors. CX. Candidate irreversible inhibitors of dihydrofolic reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazine. IV.
    Baker BR; Lourens GJ
    J Med Chem; 1968 Jan; 11(1):34-7. PubMed ID: 5237172
    [No Abstract]   [Full Text] [Related]  

  • 11. Irreversible enzyme inhibitors. LXX. Candidate active-site-directed irreversible inhibitors of dihydrofolic reductase. IV. Substituted 1-phenyl-1,2-dihydro-s-triazines.
    Baker BR; Ho BT
    J Pharm Sci; 1967 Jan; 56(1):28-32. PubMed ID: 6030489
    [No Abstract]   [Full Text] [Related]  

  • 12. Irreversible enzyme inhibitors. CIX. Candidate irreversible inhibitors of dihydrofolic reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazine. 3.
    Baker BR; Lourens GJ
    J Med Chem; 1968 Jan; 11(1):26-33. PubMed ID: 5237171
    [No Abstract]   [Full Text] [Related]  

  • 13. Irreversible enzyme inhibitors. CXII. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazine substituted with a terminal sulfonyl fluoride. II.
    Baker BR; Lourens GJ
    J Med Chem; 1968 Jan; 11(1):38-41. PubMed ID: 5237173
    [No Abstract]   [Full Text] [Related]  

  • 14. 4,6-DIAMINO-1-ALKYL-1,2-DIHYDRO-S-TRIAZINES.
    LOMBARDINO JG
    J Med Chem; 1963 Mar; 6():213-4. PubMed ID: 14188803
    [No Abstract]   [Full Text] [Related]  

  • 15. Analogs of tetrahydrofolic acid XXII. Effects of modification of the bridge between the pyrimidyl and phenyl moieties of 2-amino-5-(3-anilinopropyl)-6-methyl-4-pyrimidinol thymidylate synthetase. 3.
    Baker BR; Coward JK
    J Pharm Sci; 1965 May; 54(5):714-9. PubMed ID: 5847011
    [No Abstract]   [Full Text] [Related]  

  • 16. Irreversible enzyme inhibitors. CLX. Some factors in cell wall transport of active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(phenylalkylphenyl)-s-triazines.
    Baker BR; Janson EE; Vermeulen NM
    J Med Chem; 1969 Sep; 12(5):898-902. PubMed ID: 5812208
    [No Abstract]   [Full Text] [Related]  

  • 17. Irreversible enzyme inhibitors. 133. Studies on differential irreversible inhibition of dihydrofolic reductase from three strains of L1210 leukemia, liver, spleen, and intestine of the mouse.
    Baker BR; Lourens GJ; Meyer RB; Vermeulen NM
    J Med Chem; 1969 Jan; 12(1):67-73. PubMed ID: 5763043
    [No Abstract]   [Full Text] [Related]  

  • 18. ANALOGS OF TETRAHYDROFOLIC ACID. XVII. ON THE MODE OF BINDING OF THE P-AMINOBENZOYL MOIETY OF N-(2-AMINO-4-HYDROXY-6-METHYL-5-PYRIMIDYLPROPYL)-P-AMINOBENZOYL-L-GLUTAMIC ACID TO DIHYDROFOLIC REDUCTASE.
    BAKER BR; JORDAAN JH
    J Med Chem; 1965 Jan; 8():35-41. PubMed ID: 14287264
    [No Abstract]   [Full Text] [Related]  

  • 19. Differential binding to the hydrophobic bonding region of T2 phage induced, Escherichia coli B, and pigeon liver dihydrofolic reductases.
    Baker BR
    J Med Chem; 1967 Sep; 10(5):912-7. PubMed ID: 4860445
    [No Abstract]   [Full Text] [Related]  

  • 20. Irreversible enzyme inhibitors. CLV. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 1-[4-(omega-aminoalkoxy)-3-chlorophenyl]-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazines bearing a terminal sulfonyl fluoride.
    Baker BR; Janson EE
    J Med Chem; 1969 Jul; 12(4):672-6. PubMed ID: 5793160
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.